EMAIL THIS PAGE TO A FRIEND

Molecular cancer therapeutics

HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors.


PMID 26271675

Abstract

The clinical benefits of chemotherapy are commonly offset by insufficient drug exposures, narrow safety margins, and/or systemic toxicities. Over recent decades, a number of conjugate-based targeting approaches designed to overcome these limitations have been explored. Here, we report on an innovative strategy that utilizes HSP90 inhibitor-drug conjugates (HDC) for directed tumor targeting of chemotherapeutic agents. STA-12-8666 is an HDC that comprises an HSP90 inhibitor fused to SN-38, the active metabolite of irinotecan. Mechanistic analyses in vitro established that high-affinity HSP90 binding conferred by the inhibitor backbone could be exploited for conjugate accumulation within tumor cells. In vivo modeling showed that the HSP90 inhibitor moiety was required for selective retention of STA-12-8666, and this enrichment promoted extended release of active SN-38 within the tumor compartment. Indeed, controlled intratumoral payload release by STA-12-8666 contributed to a broad therapeutic window, sustained biomarker activity, and remarkable degree of efficacy and durability of response in multiple cell line and patient-derived xenograft models. Overall, STA-12-8666 has been developed as a unique HDC agent that employs a distinct mechanism of targeted drug delivery to achieve potent and sustained antitumor effects. These findings identify STA-12-8666 as a promising new candidate for evaluation as novel anticancer therapeutic.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

CDS008318
(4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, AldrichCPR
C22H20N2O5
H0165
7-Ethyl-10-hydroxycamptothecin, ≥98% (HPLC), powder
C22H20N2O5
SAB1405603
Anti-CDKN3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV53629
Anti-CDKN3 antibody produced in rabbit, affinity isolated antibody
HPA039311
Anti-CDKN3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500084
Anti-CDKN3 antibody produced in rabbit, affinity isolated antibody
SAB2107030
Anti-CDKN3 antibody produced in rabbit, affinity isolated antibody
SAB1305854
ANTI-KAP (CENTER) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4502351
Anti-KAP1 antibody produced in rabbit, affinity isolated antibody
SAB2102546
Anti-TRIM28 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2102547
Anti-TRIM28 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB1406938
Anti-TRIM28 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV38681
Anti-TRIM28 antibody produced in rabbit, IgG fraction of antiserum
SAB2701980
Anti-TRIM28 antibody produced in rabbit
PLA0295
Goat anti-KAP-1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
WH0010155M1
Monoclonal Anti-TRIM28 antibody produced in mouse, clone 4E6, purified immunoglobulin, buffered aqueous solution
SAB1404789
Monoclonal Anti-TRIM28 antibody produced in mouse, clone 1D11, purified immunoglobulin, buffered aqueous solution
PLA0078
Rabbit anti-KAP-1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.